• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2400670 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2024-12-21 Sanofi Winthrop Industrie view
JYHB2400669 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2024-12-21 Sanofi Winthrop Industrie view
JYHB2400668 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2024-12-21 Sanofi Winthrop Industrie view
JYHB2400671 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2024-12-21 Sanofi Winthrop Industrie view
CYHB2400561 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
CYHB2400557 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
CYHB2400560 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
CYHB2400558 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
CYHB2400559 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
JYHZ2400026 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400023 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400024 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400022 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400025 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400028 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400027 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
CYHB2302366 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Supplementary Application 2023-10-27 Cisen Pharmaceutical Co Ltd view
CYHB2302367 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Supplementary Application 2023-10-27 Cisen Pharmaceutical Co Ltd view
CYHB2302045 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2023-09-11 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
CYHB2302041 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2023-09-11 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view